Teleflex Incorporated (NYSE:TFX - Get Free Report) hit a new 52-week low on Monday . The company traded as low as $127.18 and last traded at $127.83, with a volume of 29153 shares trading hands. The stock had previously closed at $131.93.
Analyst Ratings Changes
TFX has been the topic of several research reports. StockNews.com lowered Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Piper Sandler restated a "neutral" rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and cut their target price for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Finally, Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $181.50.
Read Our Latest Research Report on TFX
Teleflex Price Performance
The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market cap of $6.02 billion, a price-to-earnings ratio of 25.81, a PEG ratio of 1.73 and a beta of 1.19. The stock has a 50-day moving average price of $148.00 and a 200 day moving average price of $181.53.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.05%. Teleflex's dividend payout ratio (DPR) is 95.77%.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. boosted its position in shares of Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after purchasing an additional 261,279 shares in the last quarter. Geode Capital Management LLC grew its position in Teleflex by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock worth $202,161,000 after buying an additional 8,307 shares during the period. Cooke & Bieler LP increased its holdings in Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after buying an additional 195,150 shares in the last quarter. Invesco Ltd. increased its holdings in Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Teleflex by 38.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 590,529 shares of the medical technology company's stock valued at $105,102,000 after acquiring an additional 162,950 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.
Teleflex Company Profile
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
